Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to $2.3 million.

  • Cytosorbents' Prepaid Assets rose 12758.69% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 12758.69%. This contributed to the annual value of $3.3 million for FY2024, which is 7830.62% up from last year.
  • Latest data reveals that Cytosorbents reported Prepaid Assets of $2.3 million as of Q3 2025, which was up 12758.69% from $1.3 million recorded in Q2 2025.
  • Cytosorbents' Prepaid Assets' 5-year high stood at $3.3 million during Q4 2024, with a 5-year trough of $880363.0 in Q1 2024.
  • Its 5-year average for Prepaid Assets is $2.0 million, with a median of $1.9 million in 2023.
  • Its Prepaid Assets has fluctuated over the past 5 years, first tumbled by 5274.98% in 2024, then soared by 25629.69% in 2025.
  • Cytosorbents' Prepaid Assets (Quarter) stood at $2.9 million in 2021, then decreased by 13.34% to $2.5 million in 2022, then fell by 26.28% to $1.8 million in 2023, then surged by 78.31% to $3.3 million in 2024, then dropped by 28.22% to $2.3 million in 2025.
  • Its Prepaid Assets was $2.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $3.1 million in Q1 2025.